drugset / Trial / NCT06783829
A Study of SHR-4394 Injection in Subjects With Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an open label, multi-center, multiple dose Phase I study to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-4394 injection in subjects with prostate cancer.
Timeline
- Start
- 2025-01-22
- Primary completion
- 2027-03
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR4394 | Unknown | — | — |